This compound is a spirocyclic heterocyclic molecule containing a tetrazatricyclic core with a methylsulfanyl substituent and a cyclohexane ring. It is characterized by a combination of aromatic rings, an amide group, and heterocyclic structural elements.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 2170747-00-7
2-Amino-3-fluoropyridine
n.a
5-Methoxyresorcinol
n.a
SODIUM (+)-10-CAMPHORSULFONATE
n.a
2,3,4,5,6,7-Hexamethyl-1H-indene
n.a
Trilaciclib Impurity 36
pharmaceutical intermediate synthesis
Trilaciclib Impurity 3
Pharmaceutical impurity reference standard
Tert-butyl 4-methylsulfanyl-10-oxospiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate
pharmaceutical intermediate
Tert-butyl 8-hydroxy-4-methylsulfanyl-10-oxo-spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate
Pharmaceutical intermediate for kinase inhibitors
4-methylsulfanylspiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-10-one
MORDOLIVMBQSKA-UHFFFAOYSA-N
CSC1=NC=C2C=C3C(=O)NCC4(N3C2=N1)CCCCC4
—